Daniel I. Pérez

3.6k total citations
83 papers, 2.8k citations indexed

About

Daniel I. Pérez is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Daniel I. Pérez has authored 83 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 32 papers in Pharmacology and 15 papers in Physiology. Recurrent topics in Daniel I. Pérez's work include Cholinesterase and Neurodegenerative Diseases (30 papers), Alzheimer's disease research and treatments (14 papers) and Computational Drug Discovery Methods (12 papers). Daniel I. Pérez is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (30 papers), Alzheimer's disease research and treatments (14 papers) and Computational Drug Discovery Methods (12 papers). Daniel I. Pérez collaborates with scholars based in Spain, Italy and Cuba. Daniel I. Pérez's co-authors include Ana Martı́nez, Carmen Gil, Concepción Pérez, Valle Palomo, Nuria E. Campillo, Santiago Conde, Ana Pérez‐Castillo, Vincenza Andrisano, Isabel W. C. E. Arends and Frank Hollmann and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daniel I. Pérez

80 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel I. Pérez Spain 31 1.4k 823 597 499 339 83 2.8k
Hailin Zheng China 31 828 0.6× 881 1.1× 326 0.5× 938 1.9× 332 1.0× 89 3.3k
Hassan Pajouhesh United States 14 966 0.7× 363 0.4× 465 0.8× 308 0.6× 331 1.0× 30 2.1k
Ana Castro Spain 27 1.4k 1.0× 1.0k 1.3× 1.2k 2.1× 367 0.7× 633 1.9× 78 2.9k
Tsuyoshi Hamaguchi Japan 33 1.6k 1.1× 386 0.5× 277 0.5× 1.1k 2.2× 138 0.4× 119 4.4k
Yuqiang Wang China 31 1.2k 0.9× 283 0.3× 375 0.6× 282 0.6× 75 0.2× 139 3.1k
Michael S. Malamas United States 27 1.5k 1.0× 610 0.7× 1.2k 2.0× 294 0.6× 461 1.4× 71 3.3k
Matthias Engel Germany 36 1.8k 1.3× 356 0.4× 499 0.8× 355 0.7× 141 0.4× 134 3.7k
Kui Cheng China 31 1.1k 0.8× 218 0.3× 191 0.3× 310 0.6× 95 0.3× 92 3.3k
Patrick Dallemagne France 28 996 0.7× 665 0.8× 1.5k 2.5× 248 0.5× 596 1.8× 147 3.0k
Betty Yuen Kwan Law Macao 38 2.3k 1.6× 376 0.5× 201 0.3× 495 1.0× 104 0.3× 130 4.2k

Countries citing papers authored by Daniel I. Pérez

Since Specialization
Citations

This map shows the geographic impact of Daniel I. Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel I. Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel I. Pérez more than expected).

Fields of papers citing papers by Daniel I. Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel I. Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel I. Pérez. The network helps show where Daniel I. Pérez may publish in the future.

Co-authorship network of co-authors of Daniel I. Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel I. Pérez. A scholar is included among the top collaborators of Daniel I. Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel I. Pérez. Daniel I. Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bissaro, Maicol, Davide Benedetto Tiz, Daniel I. Pérez, et al.. (2021). Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems. European Journal of Medicinal Chemistry. 216. 113331–113331. 12 indexed citations
4.
Martínez‐González, Loreto, Nicole F. Liachko, Concepción Pérez, et al.. (2020). Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis. European Journal of Medicinal Chemistry. 210. 112968–112968. 37 indexed citations
5.
6.
Lipina, Tatiana V., et al.. (2016). Inhibition of glycogen synthase kinase 3 prevents synaptic long-term depression and facilitates cognition in C57BL/6J mice. 2(2). 87–102. 3 indexed citations
7.
Sebastián-Pérez, Víctor, Daniel I. Pérez, Carmen Gil, et al.. (2016). New applications for known drugs: Human glycogen synthase kinase 3 inhibitors as modulators of Aspergillus fumigatus growth. European Journal of Medicinal Chemistry. 116. 281–289. 11 indexed citations
8.
Pérez, Daniel I., et al.. (2016). Epipericardial Fat Necrosis. Journal of Ultrasound in Medicine. 35(10). 2279–2283. 8 indexed citations
9.
Chlebek, Jakub, Angela De Simone, Anna Hošťálková, et al.. (2016). Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets. Fitoterapia. 109. 241–247. 30 indexed citations
10.
Prati, Federica, Angela De Simone, Paola Bisignano, et al.. (2014). Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors. Angewandte Chemie International Edition. 54(5). 1578–1582. 102 indexed citations
11.
Staderini, Matteo, Suzana Aulić, Manuela Bartolini, et al.. (2012). A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases. ACS Medicinal Chemistry Letters. 4(2). 225–229. 52 indexed citations
12.
Palomo, Valle, Ignacio Soteras, Daniel I. Pérez, et al.. (2011). Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities. Journal of Medicinal Chemistry. 54(24). 8461–8470. 93 indexed citations
13.
14.
Chiriano, Gianpaolo, Angela De Simone, Francesca Mancini, et al.. (2011). A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 48. 206–213. 21 indexed citations
15.
Ermondi, Giuseppe, Giulia Caron, Manuel Pérez, et al.. (2011). An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: The case of a palinurin-related data set of non-ATP competitive Glycogen Synthase Kinase 3β (GSK-3β) inhibitors. European Journal of Medicinal Chemistry. 46(3). 860–869. 18 indexed citations
16.
Pérez, Daniel I., Carmen Gil, & Ana Martı́nez. (2010). Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Medicinal Research Reviews. 31(6). 924–954. 126 indexed citations
17.
Pérez, Daniel I., et al.. (2009). Visible light-driven and chloroperoxidase-catalyzed oxygenation reactions. Chemical Communications. 6848–6848. 111 indexed citations
18.
19.
Schluger, Neil W., et al.. (2002). Reconstitution of Immune Responses to Tuberculosis in Patients With HIV Infection Who Receive Antiretroviral Therapy. CHEST Journal. 122(2). 597–602. 70 indexed citations
20.
Pérez, Daniel I., et al.. (1996). Enfermedades por inmunosupresión asociadas al virus de la leucemia felina. 16(3). 142–164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hailin Zheng Breakdown of academic impact, for papers by Hassan Pajouhesh Breakdown of academic impact, for papers by Ana Castro Breakdown of academic impact, for papers by Tsuyoshi Hamaguchi Breakdown of academic impact, for papers by Yuqiang Wang Breakdown of academic impact, for papers by Michael S. Malamas Breakdown of academic impact, for papers by Matthias Engel Breakdown of academic impact, for papers by Kui Cheng Breakdown of academic impact, for papers by Patrick Dallemagne Breakdown of academic impact, for papers by Betty Yuen Kwan Law
Rankless by CCL
2026